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Abstract Traumatic brain injury is a heterogeneous and
multifaceted neurological disorder that involves diverse
pathophysiological pathways and mechanisms. Thorough
characterization and monitoring of the brain’s status after
neurotrauma is therefore highly complicated. Magnetic
resonance imaging (MRI) provides a versatile tool for in
vivo spatiotemporal assessment of various aspects of
central nervous system injury, such as edema formation,
perfusion disturbances and structural tissue damage. More-
over, recent advances in MRI methods that make use of
contrast agents have opened up additional opportunities for
measurement of events at the level of the cerebrovascula-
ture, such as blood–brain barrier permeability, leukocyte
infiltration, cell adhesion molecule upregulation and
vascular remodeling. It is becoming increasingly clear
that these cerebrovascular alterations play a significant
role in the progression of post-traumatic brain injury as
well as in the process of post-traumatic brain repair.
Application of advanced multiparametric MRI strategies
in experimental, preclinical studies may significantly aid
in the elucidation of pathomechanisms, monitoring of
treatment effects, and identification of predictive markers
after traumatic brain injury.




Magnetic resonance imaging (MRI) is a versatile modality
for in vivo imaging of the central nervous system (CNS).
The technique relies on detection of MR signals from the
highly abundant water protons in tissues. Its versatility
stems from the ability to sensitize MRI acquisitions to
distinct parameters, such as proton density, MR relaxation
times (T1,T 2), susceptibility contrast, diffusion, perfusion
and flow. This enables multiparametric imaging studies on
different pathophysiological events that are involved in the
evolution of CNS injury, e.g., after neurotrauma. Further-
more, the availability of MRI in hospital and laboratory
settings facilitates the translation between clinical and
preclinical research. Hence, MRI studies in experimental
models of CNS injury can contribute to the characterization
of pathomechanisms and treatment effects, which may lead
to improvements in diagnosis and therapeutic strategies
after CNS injury.
MRI of Tissue and Perfusion Status
MRI in animal models of traumatic brain injury and other
CNS diseases most often involve T2-, diffusion- and/or
perfusion-weighted imaging to measure changes in brain
tissue and perfusion status (for a review, see Dijkhuizen and
Nicolay [1]). The transverse relaxation time of the MR
signal, T2, is dependent on the interstitial water content and
increases when intercellular or vasogenic edema develops.
This has been demonstrated with T2-weighted MRI in rats
in the first days after controlled cortical impact injury [2–5],
closed-head injury [6, 7] and lateral fluid percussion injury
[8]. While T2-weighted MRI serves as a reliable tool to
determine the extent and location of CNS lesions at
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detected with diffusion-weighted MRI. Reduction of the
apparent diffusion coefficient (ADC) or diffusivity of tissue
water, most likely reflective of cytotoxic cell swelling [9],
has been detected within hours after experimental traumatic
brain injury, which precedes severe tissue damage, e.g., loss
of cellularity, and resultant ADC elevations at later stages
[6–8, 10–12]. Furthermore, with diffusion tensor imaging
[13], it has been shown that changes in diffusion anisotropy
and axial diffusivity in gray and white matter can inform on
the extent of pericontusional and diffuse axonal injury after
controlled cortical impact in mice [14] and head accelera-
t i o ni nr a t s[ 15], respectively. These studies reported
permanent loss of diffusion anisotropy and initial decline,
followed by rise of diffusivity, which correlated with axonal
degeneration and demyelination.
The combination of T2- and/or diffusion-weighted MRI
with perfusion-weighted MRI allows concurrent assessment
of tissue lesions and perfusion alterations. Two perfusion-
weighted MRI strategies that are frequently applied are
dynamic susceptibility contrast (DSC)-enhanced MRI and
arterial spin labeling (ASL) [16–18]. DSC MRI allows
calculation of various hemodynamic parameters from MR
signal changes caused by first passage of an intravascular
bolus of contrast agent. ASL is based on spatially selective
inversion or saturation of incoming arterial spins and
subsequent detection of labeled blood water in perfused
tissue, which enables quantification of cerebral blood flow.
Both methods have been applied in rodent models of
traumatic brain injury, and have provided insights into the
development of focal as well as global post-traumatic
cerebral hypoperfusion [7, 11, 19–22]. Figure 1 demon-
strates how multiparametric MRI can inform on the
spatiotemporal profile of tissue and perfusion changes after
experimental traumatic brain injury. T2, diffusivity and
cerebral blood flow (CBF) maps, acquired in studies by
Immonen et al. [8] and Hayward et al. [20, 23], reveal first
signs of secondary injury which slowly evolves from the
primary contusion site at a subacute stage after lateral fluid
percussion injury in rats, eventually resulting in an enlarged
lesion at chronic stages.
Post-traumatic Cerebrovascular Changes
Abovementioned conventional MRI strategies allow depic-
tion of edema formation and perfusion disturbances, which
can be useful for diagnosis and treatment evaluation after
traumatic brain injury. Nevertheless, the pathophysiology of
neurotrauma is highly heterogeneous and complex, and
involves various primary and secondary neuropathological
pathways [24, 25]. In particular, increasing evidence points
towards a major role for inflammatory events in the
development of secondary tissue damage following traumatic
brain injury, while inflammation has also been implicated in
post-traumatic regenerative processes [26–29]. Associated
cerebrovascular changes, such as blood–brain barrier (BBB)
breakdown, upregulation of cell adhesion molecules, leuko-
cyte infiltration and vascular remodeling, may strongly
contribute to secondary hypoperfusion and edema formation
after the primary insult, but might also play a part in post-
traumatic tissue repair mechanisms [25, 27, 30, 31].
Elucidation of such pathways may contribute to improve-
ment of assessment of injury severity, prediction of lesion
progression and identification of targets for interventions
after traumatic brain injury. The following paragraphs will
briefly describe how specific contrast-enhanced MRI strate-
gies may aid in gaining insights in abovementioned events in
relation to neurotrauma.
MRI of BBB Permeability
Assessment of BBB integrity with MRI is based on
detection of leakage of MR contrast agent from vascular
into parenchymal space in CNS tissue [32, 33]. Intrave-
nously administered paramagnetic contrast agent that leaks
out and accumulates in brain parenchyma when microvas-
cular barriers are disrupted, will result in local changes in
MR signal intensity. The most frequently used contrast
media are gadolinium-containing compounds, such as Gd-
DTPA chelate, that locally shorten the longitudinal relax-
ation time, T1, of the MR signal. Contrast agents are usually
injected as a bolus; however, step-down infusion may
improve contrast enhancement through higher contrast
agent concentrations in plasma and tissue [34]. Contrast-
enhanced BBB permeability imaging usually involves a
static approach, in which T1-weighted MRI is executed at a
specific time-point (typically 10–30 min) after contrast
agent injection, to detect hyperintense signal intensities
generated by extravasated contrast agent. This is a fast,
simple and sensitive method, but it merely provides
qualitative information on the integrity of the BBB.
Quantification of BBB leakage is feasible with dynamic
contrast-enhanced (DCE) imaging, involving repetitive T1-
weighted MR image acquisition, and analysis with a tracer
kinetic model to assess contrast agent concentration
changes in tissue and vasculature as a function of time
[33]. This allows calculation of the blood-to-tissue volume
transfer constant, Ki or K
trans, as well as other parameters,
such as the extravascular extracellular space volume.
Analytical approaches that are frequently applied include
Tofts’ compartmental analysis [35] and multiple time-
graphic, or Patlak plot analysis [36]. Quantification of
BBB permeability with these analysis methods, however,
relies on certain physiological assumptions that may not
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because of deviations in vascular delivery and cellular
uptake of the tracer.
Serial BBB permeability MRI studies, particularly in
cerebral ischemia–reperfusion models, have provided
evidence for early and late BBB breakdown after
experimental CNS injury [37–39]. However, the exact
temporal profile of BBB permeability changes is still
unclear, as studies include reports of persistent [39], as
well as biphasic BBB opening [38]. Acute, transient BBB
leakage, as detected with post-contrast T1-weighted MRI,
has been shown after experimental traumatic brain injury,
and may be prolonged by a post-traumatic secondary insult
[40, 41]. In rabbits with weight-drop induced traumatic
brain injury, serial DCE MRI revealed increasing K
trans in
the focal lesion area from 3 h to 3 days post-trauma [42]
(Fig. 2). This was followed by a gradual decline, but K
trans
remained elevated up to 30 days as compared to animals
with sham injury.
MRI of Leukocytes
Cellular MRI is based on the detection of cells that have
been labeled with MR contrast agent, such as paramagnetic
chelates, superparamagnetic particles or
19F MRI-detectable
fluorinated particles (for reviews, see Modo et al. [43] and
Stoll and Bendszus [44]). MRI-based visualization of
various types of hepatobiliary, hematopoietic, immune and
stem cells, has most frequently relied on labeling with
superparamagnetic iron oxides [43]. These particles, gener-
ally ranging in size from a few nanometers to more than a
micrometer, can induce very strong contrast effects by local
shortening of the T2 or T
»
2, resulting in hypointense signal
Fig. 1 Maps of T2 (a–c), Dav (‘average diffusivity’ = 1/3 of the trace
of the diffusion tensor) (d–f), and CBF (g–i) of a coronal brain slice
from control rats (left column), and rats at 2–3 weeks (middle column)
and 8 months after lateral fluid percussion injury (right column). Data
are acquired from a quantitative MRI study by Immonen et al. [8]( a
and d, b and e, and c and f are map pairs from the same animal,
respectively) and CBF studies by Hayward et al. [20, 23], executed on
a 4.7-T MR system with quadrature surface coil as radio-frequency
transmitter/receiver (for T2 and Dav mapping), or a combination of an
actively decoupled linear volume transmission coil and quadrature
surface receiver (for CBF mapping with ASL). The parametric MRI
maps demonstrate that at the cortical contusion site (*), a lesion/cyst
was formed which slowly expanded (together with enlarging
ventricles) up to several months post-injury. The perilesional cortical
area (white arrows) and remaining tissue in the hippocampus
ipsilateral to the contusion site (black arrows) show gradual increase
in T2 and diffusivity from 2 to 3 weeks post-injury onwards, indicative
of progression of neurodegeneration (acute alterations in T2 and
diffusivity during the first week post-injury are edema-related and
resolved by 2 weeks; data not shown). CBF was decreased in the
perilesional area and in the ipsilateral hippocampus 2 weeks post-
injury, and remained lowered 8 months later. At this chronic stage
increased CBF is apparent in the ipsilateral thalamus (arrowhead).
Scale bar = 1 mm (Courtesy of Drs. Riikka Immonen, Nick Hayward
and Olli Gröhn)
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2-weighted (gradient echo)
MR images. Basically two approaches for cellular labeling
have been employed: (1) in vivo uptake of intravenously
injected contrast agent by (circulating) phagocytic cells or
(2) in vitro labeling of isolated cells that are subsequently
reinjected. Ultrasmall particles of iron oxide (USPIOs) with
a long blood half-life have been mostly applied for in vivo
uptake by monocytes or macrophages, whereas larger
particles of iron oxide (such as small particles of iron oxide
(SPIOs) or micron-sized particles of iron oxide (MPIOs)),
which provide maximum contrast effects, may be effec-
tively used for in vitro cell labeling [43, 44]. Both cell
labeling strategies have been applied in a number of
experimental studies that sought to characterize the spatio-
temporal profile of leukocyte infiltration in neuroinflamma-
tory diseases, such as multiple sclerosis and stroke (see
Stoll and Bendszus [44] and references therein). These
studies have, for instance, shown that cellular infiltration is
not necessarily linked to BBB disruption. In a controlled
cortical impact injury model in mice, intravenous MPIO
injection resulted in discrete, punctuate areas of MRI
hypointensity in and around contusion sites (see Fig. 3),
which correlated histologically with presence of MPIO-
containing macrophages [45]. This was evident even when
MPIOs were administered 6 days before neurotrauma,
which suggests that previously labeled macrophages
migrate to the trauma site and that the hypointense MR
signals were not caused by nonspecific accumulation of
MPIO particles that traversed an acutely leaky BBB.
MRI of Cell Adhesion Molecules
Advances in design and synthesis of contrast agents have
recently initiated MRI studies that take advantage of
molecular targeting with tailored contrast agents to measure
particular disease markers [46–49]. This kind of molecular
imaging with MRI typically employs (super)paramagnetic
nano- or microparticles with conjugated ligand, e.g., an
antibody.Besidea(super)paramagneticagent,e.g.,gadolinium
Fig. 2 K
trans map (a) derived from DCE MRI of rabbit brain 3 days
after weight drop induced traumatic brain injury [42]. BBB perme-
ability is increased in focal and perifocal lesion areas as compared to
contralateral. Graphs (b) show K
trans in different brain areas over time
after traumatic brain injury or sham injury. In the focal lesion area (top
graph), K
trans was consistently higher than in comparable brain
regions of sham-operated animals from 3 h up to 30 days after
traumatic brain injury, peaking around day 3. In the perifocal area
(middle graph), K
trans was higher at 1, 3 and 7 days post-trauma, as
compared to the sham group. In contralateral brain tissue (bottom
graph), K
trans was similar in the traumatic brain injury and sham injury
groups at all time-points. Exact details of the location and size of the
regions-of-interest are described by Wei et al. [42]. Data represent
mean ± SD.
*P<0.01 as compared to the sham group. The publisher
for part of this copyrighted material is Mary Ann Liebert, Inc.
publishers (Courtesy of Dr. Xiao-Er Wei)
b
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fluorescent dye, for detection with alternative imaging
modalities. In addition, polyethylene-glycol coating is often
used to increase circulation time and bioavailability.
Molecular MRI contrast agents can be constructed by
direct functionalization of (super)paramagnetic agents or
particles (e.g., MPIOs) with targeting peptides or antibodies
[50]. An alternative platform for the design and formation
of molecular imaging probes makes use of lipid formula-
tions, such as liposomes and micelles, that are build up
from amphiphilic lipids [51] (Fig. 4). These lipid-based
structures can carry various contrast agents in relatively
high amounts, which, in combination with the ease of
preparation, flexibility and biocompatibility, make these
nanoparticles highly adequate for preclinical cellular and
molecular imaging studies as well as for drug delivery in
patients [52].
Despite the potential of targeted contrast agents to bind
and depict molecular markers, molecular MRI studies in the
brain are complicated due to the presence of the BBB,
which restricts the blood-to-brain transfer of relatively large
intravascular molecular MRI probes. For that reason
Fig. 3 High-resolution T
»
2-weighted MR images (acquired with a
11.7-T MR system) of coronal sections of excised brain from: a a
naive mouse with no contrast injection; b a naive mouse that was
injected 24 h earlier with MPIO particles; c a mouse injected with
MPIO particles at 24 h and imaged at 48 h after controlled cortical
impact injury; d a mouse injected with MPIO particles at 48 h and
imaged at 72 h after controlled cortical impact injury; e a mouse
injected with MPIO particles at 6 days before and imaged at 48 h after
controlled cortical impact injury (from Foley et al. [45]). A low level
of randomly localized areas of punctuate hypointensity (arrows)
representing MPIO particles was identified after injection of MPIO
particles in naive mice (b). More robust contusional and peri-
contusional accumulation of particles was found in mice injected with
MPIO particles after controlled cortical impact injury (c, d),
particularly when particles were injected at 48 h post-trauma and
imaged 24 h thereafter (d). Smaller numbers of particles were
observed in mouse brain at 48 h post-trauma when MPIO particles
were injected 6 days prior to traumatic brain injury (e). The publisher
for this copyrighted material is Mary Ann Liebert, Inc. publishers
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detection of markers that are expressed on the luminal side of
cerebral blood vessels, such as cell adhesion molecules.
Studies in rodent models of neuroinflammatory diseases have
demonstrated that paramagnetic or superparamagnetic com-
pounds targeted against endothelial cell adhesion molecules,
such as P- and E-selectin and VCAM-1, induce local contrast
enhancement on T1-o rT
»
2-weighted MR images, respective-
ly, reflective of activated cerebral endothelium [53–56]. In a
model of lateral fluid percussion in rats, Chapon et al. [57]
recently showed that injection of selectin-targeted iron oxide
particles resulted in persistent T
»
2 shortening in the trauma-
tized brain hemisphere, while initial T
»
2 shortening recovered
within 1 h after injection of non-targeted iron oxide particles.
MRI of Vascularity
There is increasing evidence that chronic vascular remodel-
ing can occur after CNS injury, which may contribute to
Fig. 4 Schematic representation of two types of lipid-based nano-
particles, i.e., micelles and liposomes, that can be formed with
various constituents, such as MR contrast agent, fluorescent dye,
polyethylene-glycol (PEG), and a targeting ligand for molecular
imaging purposes. Courtesy of Drs. Geralda A. van Tilborg and
Willem J. Mulder
Fig. 5 ΔR2 (a) and Q map (b) calculated from steady-state contrast-
enhanced MRI of a coronal rat brain slice with a subcortical infarct at
7 days after transient unilateral middle cerebral artery occlusion, and
corresponding histological sections with vessel staining of the ipsi- (c)
and contralesional hypothalamic region (d). Relatively high ΔR2 after
administration of a superparamagnetic blood pool agent (USPIO)
indicates a high density of microvessels with a relatively small
diameter in the ipsilesional hypothalamic region (black arrow)a s
compared to contralesional (white arrow)( a). This area also revealed a
high Q value (b), reflective of enhanced microvessel density, which
was confirmed by more vessel staining with von Willebrand Factor
(DAB-enhanced; brown) in the ipsi- (c) as compared to contralesional
hypothalamic region (d) (nuclei were stained with hematoxylin; blue).
Modified from Seevinck et al. [59] (Courtesy of Peter R. Seevinck,
Lisette H. Deddens and H. Elga de Vries)
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tissue repair [31, 58]. Preclinical studies have reported
traumatic brain injury-induced angiogenesis, which could
be promoted with specific therapeutic interventions, leading
to improvement of functional outcome [31]. Hayward et al.
[23] have recently detected brain region-specific increases
in vascular density at 9 months after lateral fluid percussion
injury in rats, which, however, showed no clear correlation
with restoration of CBF or recovery of neurological
function. Evidently, the pattern of changes in brain tissue
vascularity and its relation to pathophysiology or plasticity
after neurotrauma require further investigation.
Various MRI methods are available for detection of
vascular changes in injured brain (for a review, see Seevinck
et al. [59]). A particularly powerful approach is offered by
steady-state contrast-enhanced MRI, which involves concur-
rent gradient echo and spin echo MRI acquisition in
combination with injection of a superparamagnetic blood
pool agent (e.g., USPIOs). This enables measurement of
changes in MR relaxation rates R
»
2 and R2 that are dependent
on local cerebral blood volume (CBV), which allows
calculation of different vascular parameters, such as total
and microvascular blood volume fraction, microvessel
density, and vessel size index [59, 60]. A serial steady state
contrast-enhanced MRI study in rats after experimental
stroke has reported chronically increased microvascular
CBV and microvessel density subsequent to subacute
vascular compression, pointing toward active revasculariza-
tion of post-ischemic tissue [61]. Figure 5 shows steady state
contrast-enhanced MRI data obtained from a rat at 7 days
after subcortical stroke. The elevated ΔR2 (a measure of
microvascular CBV) and Q ð$R2=ð$R
»
2Þ
2=3; a measure of
microvessel density) in part of the lesion reflect increased
vascularization, which was confirmed histologically [59].
Conclusion
Recent MRI strategies that focus on detection of specific
cerebrovascular alterations associated with neurological
disorders have advanced the abilities of integrative in vivo
studies on the pathophysiology of CNS injury. In particular,
the developments in contrast agent chemistry have provided
unique opportunities for in vivo MRI-based detection of
cellular and molecular processes at the level of the
cerebrovasculature, such as the invasion of leukocytes and
upregulation of cell adhesion molecules. The application of
these cellular and molecular MRI methods in combination
with other structural and functional MRI techniques, allows
direct correlation of different pathophysiological events in
an experimental setting, which can contribute to elucidation
of the interaction between the various pathways through
which traumatic brain injury develops. Furthermore, pre-
clinical experiments with multiparametric MRI protocols
may lead to the identification of exclusive disease bio-
markers and distinctive therapeutic targets that can be
translated to the clinic. The potential of advanced MRI
techniques, such as susceptibility-weighted MRI and
diffusion tensor imaging, to aid in the classification of
traumatic brain injury patients has recently been described
by Kou et al. [62]. These methods, in combination with
functional MRI, may also inform on brain remodelling or
neural plasticity at later post-traumatic stages [63], which
could lead to identification of key processes that contribute
to functional recovery and may be stimulated with
therapeutic strategies.
In conclusion, studies with novel contrast-enhanced MRI
strategiesinanimalmodelswill provide moreinsightsintothe
potential of these methods in terms of their sensitivity and
specificity to detect distinctive characteristics of traumatic
brain injury. The outcome of such studies, as well as adequate
evaluation of safety issues, will be critical to determine
whether these contrast-enhanced MRI techniques have poten-
tial for clinical application in neurotrauma patients.
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